These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3227479

  • 1. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA, Savenkov MP.
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of ticlopidine and dipyridamole on platelet aggregation and count in patients with chronic stable angina pectoris].
    Ramires JA, Mansur Ade P, Martins JR, Raineri A, Cesar LA, Bellotti G, Chamone DF, Pileggi F.
    Arq Bras Cardiol; 1991 Apr; 56(4):323-7. PubMed ID: 1888308
    [Abstract] [Full Text] [Related]

  • 3. Platelet function inhibitors: their clinical use.
    Fuster V, Didisheim P.
    Adv Intern Med; 1978 Apr; 23():251-64. PubMed ID: 343540
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, Shiku H, Ikeda Y, Ito M, Isaka N, Nakano T.
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [Abstract] [Full Text] [Related]

  • 5. [Platelet antiaggregants and arteriopathies].
    Cristol R.
    J Mal Vasc; 1981 Aug; 6(3):237-41. PubMed ID: 7026714
    [No Abstract] [Full Text] [Related]

  • 6. Antiplatelet therapy.
    Sloan RW.
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [Abstract] [Full Text] [Related]

  • 7. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.
    Am J Cardiol; 2005 Oct 15; 96(8):1095-9. PubMed ID: 16214444
    [Abstract] [Full Text] [Related]

  • 8. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M.
    Clin Ter; 1979 Oct 31; 91(2):117-27. PubMed ID: 396098
    [No Abstract] [Full Text] [Related]

  • 9. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV.
    Kardiologiia; 1989 Sep 31; 29(9):116-20. PubMed ID: 2687554
    [No Abstract] [Full Text] [Related]

  • 10. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G, Skowasch D, Schneider M, Andrié R, Jabs A, Lüderitz B.
    Am Heart J; 2003 Feb 31; 145(2):343-8. PubMed ID: 12595854
    [Abstract] [Full Text] [Related]

  • 11. [Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
    Davì G, Botindari G, Catalano I, Strano A.
    Cardiologia; 1988 Feb 31; 33(2):123-6. PubMed ID: 3282656
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH, Madsen JK, Kastrup J.
    Ugeskr Laeger; 2004 Apr 26; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract] [Full Text] [Related]

  • 13. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS.
    Med J Aust; 1985 Jan 07; 142(1):41-7. PubMed ID: 3880861
    [Abstract] [Full Text] [Related]

  • 14. Status of antiplatelet drugs in coronary heart disease.
    Mehta J, Mehta P.
    JAMA; 1979 Jun 15; 241(24):2649-51. PubMed ID: 439365
    [No Abstract] [Full Text] [Related]

  • 15. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G.
    Minerva Cardioangiol; 1980 Oct 15; 28(10):723-6. PubMed ID: 7465066
    [No Abstract] [Full Text] [Related]

  • 16. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.
    Am Heart J; 2003 Oct 15; 146(4):713-20. PubMed ID: 14564328
    [Abstract] [Full Text] [Related]

  • 17. [Current clinical results of antiplatelet medication].
    Ordinas A.
    Sangre (Barc); 1984 Oct 15; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
    Avellone G, Mandalà V, Novo S, Davì G, Pinto A, Riolo FP.
    Boll Soc Ital Cardiol; 1979 Oct 15; 24(11):1229-33. PubMed ID: 261907
    [No Abstract] [Full Text] [Related]

  • 19. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M.
    Recenti Prog Med; 1980 Apr 15; 68(4):361-81. PubMed ID: 6992244
    [No Abstract] [Full Text] [Related]

  • 20. [Antiplatelet agents (inhibitors of platelet function) orally administered. Bases for their practical use in coronary artery disease].
    Lecompte T, de Maistre E.
    Arch Mal Coeur Vaiss; 1996 Nov 15; 89(11 Suppl):1507-13. PubMed ID: 9092411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.